A covalent phage display approach to identify complement-targeted autoimmune therapeutics

Project Code

MRCIIAR26Ba Lovell

Project Type

Wet lab

Research Theme

Infection, Immunity, Antimicrobial Resistance and Repair

Project Summary Download

Summary

Complement is an ancient, conserved system vital for defence against pathogens and maintaining tissue homeostasis. However, dysregulation can cause damage contributing to many autoimmune and inflammatory diseases. Despite its therapeutic potential, few complement-targeting drugs have been approved. Selective inhibition of key complement proteins offers a promising approach. This proposal aims to develop targeted covalent macrocycle inhibitors of complement serine proteases using molecular, chemical, and structural biology tools, advancing next generation complement therapies toward clinical application.

Lead Supervisor

Dr Scott Lovell

Lead Supervisor Email

sdl35@bath.ac.uk

University Affiliation

Bath